Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Int Forum Allergy Rhinol. 2015 Apr 23;5(9):829–838. doi: 10.1002/alr.21543

Table 6.

Comparison of mean improvement in quality of life scores for CRS patients with and without comorbid anxiety

CRS with comorbid anxiety
(n=20)
CRS without comorbid
anxiety
(n=92)
Quality of life measures: Mean [SD] Relative
Change
Mean [SD] Relative
Change
p-value
SNOT-22 total score −18.1[19.5] ** 31% −29.0[21.0] * 52% 0.03
  Rhinologic symptoms −5.4[6.4] ** 34% −9.0[6.3] * 53% 0.02
  Extra-nasal rhinologic symptoms −2.4[4.0] ** 31% −4.3[3.7] * 52% 0.08
  Ear and/or facial symptoms −4.3[3.9] * 42% −5.5[5.0] * 56% 0.28
  Psychological dysfunction −5.2[8.4] ** 27% −8.3[8.5] * 49% 0.19
  Sleep dysfunction −4.2[7.1] ** 28% −7.7[7.1] * 49% 0.04
RSDI total scores −17.3[29.3] ** 32% −26.5[22.4] * 57% 0.12
  Physical subdomain −6.9[9.8] ** 34% −11.7[9.1] * 61% 0.05
  Functional subdomain −6.1[10.2] ** 36% −8.8[8.4] * 59% 0.29
  Emotional subdomain −4.3[12.0] 25% −5.9[7.6] * 48% 0.59
*

indicates significant postoperative improvement over time (p<0.001)

**

indicates significant postoperative improvement over time (p<0.050).

Negative mean scores indicate improvement over time. SD, standard deviation; SNOT-22, 22-item Sinonasal Outcome Test; RSDI, Rhinosinusitis Disability Index.